{
  "patient_id": "PATIENT_002",
  "drug": "CODEINE",
  "timestamp": "2026-02-19T13:35:00Z",
  "risk_assessment": {
    "risk_label": "Toxic",
    "confidence_score": 0.99,
    "severity": "critical"
  },
  "pharmacogenomic_profile": {
    "primary_gene": "CYP2D6",
    "diplotype": "*2/*2",
    "phenotype": "URM",
    "detected_variants": [
      {
        "rsid": "rs16947",
        "ref": "C",
        "alt": "T",
        "genotype": "1/1"
      }
    ]
  },
  "clinical_recommendation": {
    "guideline": "Avoid codeine use because of potential for serious toxicity. If opioid use is warranted, consider a non-tramadol opioid."
  },
  "llm_generated_explanation": {
    "summary": "Patient is an Ultra-Rapid Metabolizer. Codeine is highly dangerous and poses an overdose risk.",
    "biological_mechanism": "The presence of CYP2D6 rapid alleles causes increased formation of morphine from codeine. This leads to a significantly higher risk of life-threatening respiratory depression and toxicity, even at standard doses."
  },
  "quality_metrics": {
    "vcf_parsing_success": true,
    "variants_analyzed": 1
  }
}
